Quest Diagnostics Incorporated (DGX)
After hours:
| Previous Close | 138.53 |
| Open | 138.00 |
| Bid | 137.30 x 800 |
| Ask | 138.99 x 900 |
| Day's Range | 137.01 - 139.18 |
| 52 Week Range | 119.59 - 145.62 |
| Volume | |
| Avg. Volume | 917,892 |
| Market Cap | 15.314B |
| Beta (5Y Monthly) | 0.89 |
| PE Ratio (TTM) | 18.55 |
| EPS (TTM) | 7.43 |
| Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 3.00 (2.18%) |
| Ex-Dividend Date | Jul 08, 2024 |
| 1y Target Est | 147.07 |
ACCESSWIREMy Quest Story - Mark Hamilton
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Quest Diagnostics I've spent most of my career working in an industry where lives are on the line. Prior to coming to Quest Diagnostics, I worked in transportation in the airline industry as a ramp agent. ...
PR NewswireQuest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.
ACCESSWIREQuest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
SECAUCUS, NJ / ACCESSWIRE / June 10, 2024 / Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic information services, today announced that its Board of Directors has elected Robert (Rob) B. Carter, a seasoned technology executive, to serve ...
